Information for "STARC"
Jump to navigation
Jump to search
Basic information
| Display title | STARC |
| Redirects to | Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study (info) |
| Default sort key | STARC |
| Page length (in bytes) | 283 |
| Namespace ID | 0 |
| Page ID | 173396 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | DaveBot (talk | contribs) |
| Date of page creation | 19:25, 6 July 2009 |
| Latest editor | Vendhan Ramanujam (talk | contribs) |
| Date of latest edit | 03:52, 21 August 2013 |
| Total number of edits | 2 |
| Total number of distinct authors | 2 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |